Oncopharmpod
Early July FDA Updates
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:13:29
- Mas informaciones
Informações:
Sinopsis
FDA ended June with 5 new approvals. *selinexor for r/r DLBCL *pembrolizumab for cutaneous squamous cell carcinoma *pembrolizumab for MSI-h/dMMR met. colorectal cancer *avelumab maintenance for met. bladder cancer *SC trastuzumab/pertuzumab/hyaluronidase
